Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,865.00
+10.00 (0.26%)
At close: Oct 2, 2025
0.26%
Market Cap107.11B
Revenue (ttm)108.14B
Net Income (ttm)1.41B
Shares Out27.68M
EPS (ttm)60.34
PE Ratio64.14
Forward PEn/a
Dividend30.00 (0.78%)
Ex-Dividend DateMar 4, 2025
Volume93,928
Average Volume286,534
Open3,850.00
Previous Close3,855.00
Day's Range3,830.00 - 3,890.00
52-Week Range2,995.00 - 4,890.00
Beta0.43
RSI45.88
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.